Whither combine? New opportunities for receptor-based QSAR

Area of Science:

• Computational chemistry
• Medicinal chemistry
• Pharmacology

Background:

• Receptor-based quantitative structure-activity relationship (QSAR) methods merge structure-activity relationship analysis with receptor structure-based design.
• These methods provide significant pharmacological insights for diverse therapeutic targets.

Purpose of the Study:

• To review the methodology of Comparative Binding Energy (COMBINE) analysis.
• To contrast COMBINE with other 3D QSAR techniques.
• To highlight recent innovations and applications of COMBINE analysis.

Main Methods:

• COMBINE analysis explicitly uses interatomic interactions between ligands and receptors as QSAR variables.
• The review discusses the integration of multiple receptors into unified COMBINE models.
• Extensions to account for covalent effects and applications in high-throughput virtual screening are presented.

Main Results:

• Unified COMBINE models effectively probe bioactivity trends across homologous protein receptors and within single protein conformational variations.
• The method has been successfully extended to include covalent binding effects.
• COMBINE models have demonstrated efficacy in high-throughput virtual screening.

Conclusions:

• COMBINE analysis is a powerful tool for drug discovery and understanding ligand-receptor interactions.
• Future refinements may include extensions to four-dimensional QSAR and the integration of quantum chemistry.
• The method shows promise for addressing covalent bonding and enhancing parametric adaptivity in QSAR studies.